Institute of Asthma and Allergy Prevention, IAP, Environmental Health Center, Helmholtz Munich

Environmental Health Center

The Unit Global Health (UGH) focuses on collaborative research to solve pressing global health problems by bringing together scientists from Helmholtz Munich and low- and middle-income countries (LMICs). A major area of research in the UGH is lung health, its determinants and the role of infections with respiratory pathogens. In collaboration with the Computational Health Center at Helmholtz Munich, the UGH is pioneering the integration of artificial intelligence (AI) in several key areas of global health research, such as biomarker research, the development of digital health applications and population-based health prediction tools.

Click & View

Picture2_Mekota_TBSequel_MRC_TheGambia_TB_Clinic

As part of the research projects in the Global Health Unit, we aim to investigate the pathways and drivers of Chronic Respiratory Diseases in low- and middle-income countries to understand similarities and differences compared to patient populations in high-income countries, which are much better studied until now.

Dr. Noemi Castelletti

Ms. Marlene Hannes

Dr. Kathrin Held

Guest Researcher

Prof. Dr. med. Michael Hoelscher

Unit Head

PD Dr. med. Andrea Rachow

Deputy Unit Head

2024 Lancet Infect Dis

Olbrich L, Verghese VP, Franckling-Smith Z, Sabi I, Ntinginya NE, Mfinanga A et al.

Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countries

2024 Nat Commun

Merkt S, Ali S, Gudina EK, Adissu W, Gize A, Muenchhoff M et al.

Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity

2024 Pathoc Immun.

Zielinski N, Baiceanu D, Dragomir A, Heyckendorf J, Ibraim E, Köhler N, Leschczyk C, Popa C, Rachow A, Sachsenweger J, Carballo PS, Schaub D, Zeeb H, Tulu B, DiNardo AR, Lange C, Reimann M

Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis

2024 EClinicalMedicine

Glover NA, Ivanova O, Sathar F, Riess F, Shambhu RR, Mekota A-M et al.

Lung outcomes and related risk factors in patients after SARS-CoV-2 infection: a hospitalised single-centre cohort from Johannesburg, South Africa

2023 Nat Med.

Schommers P, Kim DS, Schlotz M, Kreer C, Eggeling R, Hake A et al.

Dynamics and durability of HIV-1 neutralization are determined by viral replication

2023 Nat Commun

Menzies NA, Allwood BW, Dean AS, Dodd PJ, Houben RMGJ, James LP et al.

Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis